AT205705T - Pharmaceutical composition.

32 members in 19 offices

This recordMember, by publication datePriority claim9 more offices are in the list below

Priority claims
Document	Office	Kind	Date
21734494	United States of America	A	1994-03-23

Family members, oldest first
Document	Office	Kind
WO9524819A1	World Intellectual Property Organization (WIPO)	A1	1995-09-14
CA2142653A1	Canada	A1	1995-09-24
ZA952169B	South Africa	B	1995-09-26
EP0673645A2	European Patent Office (EPO)	A2	1995-09-27
AU1488295A	Australia	A	1995-10-05
US5457360A	United States of America	A	1995-10-10
JPH07277958A	Japan	A	1995-10-24
CN1112417A	China	A	1995-11-29
US5482718A	United States of America	A	1996-01-09
EP0698336A1	European Patent Office (EPO)	A1	1996-02-28
BR9505785A	Brazil	A	1996-03-05
KR960702728A	Republic of Korea	A	1996-04-27
CN1124560A	China	A	1996-06-12
EP0673645A3	European Patent Office (EPO)	A3	1996-07-24
JPH08510592A	Japan	A	1996-11-05
NZ270737A	New Zealand	A	1996-11-26
MX9504684A	Mexico	A	1997-05-31
EP0698336A4	European Patent Office (EPO)	A4	1997-10-22
PH31334A	Philippines	A	1998-07-06
JP2774080B2	Japan	B2	1998-07-09
AU696943B2	Australia	B2	1998-09-24
KR100210275B1	Republic of Korea	B1	1999-07-15
RU2138251C1	Russian Federation	C1	1999-09-27
CN1047907C	China	C	1999-12-29
EP0673645B1	European Patent Office (EPO)	B1	2001-09-19
AT205705TThis record	Austria	T	2001-10-15
ATE205705T1	Austria	T1	2001-10-15
DE69522729D1	Germany	D1	2001-10-25
DK0673645T3	Denmark	T3	2001-11-12
ES2162874T3	Spain	T3	2002-01-16
PT673645E	Portugal	E	2002-03-28
DE69522729T2	Germany	T2	2002-07-04

2 legal events, as the office reported them to INPADOC

Point at a mark for the event

Legal events, newest first
	Event	Code
2003-12-15	Ceased due to non-payment of the annual feeCeasedREN	REN
2002-04-15	Publication of translation of european patent specificationUEP	UEP

CPC, 1: A61K9/2886
Filled: the office’s first classification
IPC, 8: A61K9 00
A61K9 20
A61K9 22
A61K9 28
A61K9 30
A61K9 32
A61K9 34
A61K9 36

Pharmaceutical composition.